NCT01977352View on ClinicalTrials.gov

Efficacy of Interscalene Brachial Plexus Block With Liposomal Bupivacaine for Arthroscopic Shoulder Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Shoulder PainRotator Cuff Tear
Interventions
DRUG

Liposomal bupivacaine

liposomal bupivacaine (EXPAREL®; 88 mg in 20 cc)

DRUG

Bupivacaine 0.25%

20 cc of bupivacaine 0.25%

Trial Locations (1)

10025

St. Luke's Roosevelt Hospital Center, New York

All Listed Sponsors
lead

St. Luke's-Roosevelt Hospital Center

OTHER

NCT01977352 - Efficacy of Interscalene Brachial Plexus Block With Liposomal Bupivacaine for Arthroscopic Shoulder Surgery | Biotech Hunter | Biotech Hunter